Protagonist Therapeutics, Inc — Director's Dealing 2018

Mar 16, 2018

SEC Form 4/A — Form 4/A

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2017-12-15

Reporting Person: Noonberg Sarah B. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-15	Stock Option (right to buy)	$18.99	A	24000	Acquired	2027-12-14	Common Stock (24000)	Direct

Footnotes

F1: This amendment to the previously filed Form 4 is being filed to correct a typographical error in the exercise price of the option to purchase common stock of the Issuer held by the Reporting Person.

F2: The shares subject to the option shall vest in 36 equal monthly installments from the vesting commencement date of December 12, 2017.